Within the field of stem cell biology, researchers and clinicians increasingly understand that the therapeutic mechanism of mesenchymal stem cells (MSCs) is cell-to-cell communication. These observations have since prompted the development of extracellular vesicles including exosomes as an entire category of novel therapeutics, and Direct Biologics is leading the industry in scientific & clinical research as well as product development & delivery.